强磁场影响下菌株B1对染料的脱色作用

从校园土壤中筛选出一株对人工合成染料酸性红B有一定脱色能力的菌株B1(芽孢杆菌属),经过6.0、8.0、8.0T的强磁场分别作用30、15、30 min后进行了脱色试验;根据实验数据,得到染料脱色模型.结果表明,强磁场对B1具有诱变作用,能使其脱色能力得到强化.     

沼泽红假单胞菌H3对酸性红B2GL染料的厌氧脱色和降解作用

从印染厂污泥中分离到一株沼泽红假单胞菌（ＲｈｏｄｏｐｓｅｕｄｏｍｏｎａｓｐａｌｕｓｔｒｉｓＨ３），在光照厌氧条件下该菌生长细胞可将１００ｍｇ／Ｌ酸性红Ｂ２ＧＬ染料去除到３０ｍｇ／Ｌ．完整细胞脱色的最适条件为ｐＨ７０，温度３０℃，细胞浓度２０—２５ｍｇ／ｍＬ（湿重）．低浓度的阳离子对脱色影响不大．在通Ａｒ气使严格厌氧和加有还原性辅酶Ｉ的条件下无细胞提取液的脱色活性最高，比活率为１５４×１０－２ｍｇ／（ｍｇ·ｈ）．根据降解产物的分析，推断了该菌对酸性红染料的降解代谢途径．     

活性艳红X-3B微波辅助光催化脱色的研究

研究了微波辅助光催化氧化(MW/UV/TiO2)处理活性艳红(X 3B)模拟废水。结果表明:400mg/LX 3B在反应150min时的脱色率由UV/TiO2体系的7.07%、MW体系的13.52%提高到了MW/UV/TiO2体系的56.35%。脱色反应速率随初始浓度(CX 3B)的增大而减慢;在强酸性介质中,脱色率更高;光照度(E)越强,越有利于X 3B脱色反应;改变催化剂投加量对X 3B脱色影响不大;H2O2浓度增加,X 3B脱色率升高;在以上条件下,X 3B的脱色反应均符合一级反应动力学方程,脱色反应中同时存在自由基反应与直接光解反应。     

纳米TiO_2光催化降解酸性红B的实验研究

采用偶联剂法在聚丙烯多面球表面负载化纳米TiO2,在高压汞灯照射下,以酸性红B染料为研究对象,采用光催化氧化法进行降解处理;研究了溶液初始浓度、H2O2和Fe3+投加量、pH以及光照强度等因素对酸性红B染料降解效果的影响。     

Prenatal diagnosis of GM2-gangliosidosis B1 variant

Prenatal diagnosis in a pregnancy at risk for a juvenile B1 variant of GM₂-gangliosidosis was carried out. The biochemical study of the cultured amniocytes and the affected fetal brain is reported. The results obtained show that the sulphated artificial substrate can be used in the diagnosis of B1 variant, but not the neutral one. The accumulation of GM₂-ganglioside in the fetal brain of the B1 juvenile form and an infantile form of GM₂-gangliosidosis (0 variant) was compared.     

催化光度法测定环境样品中痕量钒的研究

研究了在磷酸介质中,利用高碘酸钾氧化罗丹明B测定环境样品中痕量钒的方法,最大吸收波长530nm,表观摩尔吸光系数2.71×10~8L·mol~(-1)·cm~(-1),在0～30ng/25mL范围内符合比耳定律,用于测定自来水和小麦中钒的含量,结果令人满意。     

Prevalence and clinical significance of anticardiolipin antibodies in pregnancies complicated by parvovirus B19 infection

Anticardiolipin antibodies were measured in 60 pregnant women with acute parvovirus B19 infection. Test results for eight (13.3 per cent) women were positive for anticardiolipin antibody. Six of these eight women became negative later, yielding a prevalence of anticardiolipin antibodies of 3.3 per cent (2/60) 6 months after acute parvovirus B19 infection. Anticardiolipin antibody positivity was not associated with an increased risk of abortion, fetal death, or maternal complications. This study suggests that there is an elevated frequency of anticardiolipin antibodies in pregnant women with acute parvovirus B19, probably representing an epiphenomenon. However, this is not associated with an adverse maternal or perinatal outcome.     

A fetus with a parvovirus B19 infection and congenital anomalies

A fetus with multiple structural defects was seen at prenatal ultrasound examination. After termination of the pregnancy a bilateral cleft lip, alveolus, and palate; micrognathia; and webbed joints were seen. Fetal tissues showed indications of infection, intranuclear inclusion bodies, chronic stress, haemolysis, arterial wall damage, and profuse haemorrhage. Parvovirus B19 DNA was detected in fetal tissues by dot hybridization after polymerase chain reaction. The possibility of parvovirus B19 infection leading to congenital malformations is discussed.     

Antenatal diagnosis and palliative treatment of non-immune hydrops fetalis secondary to fetal parvovirus B19 infection

Hydrops fetalis was diagnosed at 22 weeks. An ultrasound examination demonstrated cardiomegaly and a fetal blood specimen obtained by cordocentesis revealed thrombocytopenia, anaemia, and neutropenia. Fetal paracentesis yielded straw-coloured fluid with electrolytes indicative of a transudate. Non-enveloped icosahedral viral particles approximately 23 mm in diameter were visualized in the ascitic fluid by electron microscopy. Immune electron microscopy confirmed human parvovirus B19. Direct fetal digitalization led to a reduction in umbilical artery resistance, a decline in the abdominal circumference from 20·3 to 17·8 cm, and resolution of the ascites within 72 h. Despite this dramatic response to therapy, fetal death occurred on day 5 of treatment. The initial maternal serum was positive for anti-B19 IgM and IgG antibodies. Electron microscopy of fetal cardiac tissue obtained post-mortem revealed intranuclear viral particles typical of B19, confirming the antenatal diagnosis of myocarditis. This case demonstrates that direct viral identification is applicable to prenatal diagnosis. To our knowledge, this is the first reported case of the antenatal diagnosis and palliative treatment of fetal viral infection.     

Human parvovirus B19 infection and unbalanced translocation in a case of hydrops fetalis

In a case of hydrops fetalis, serological examination showed a recent maternal human parvovirus B19 infection. Amniocentesis revealed a unique unbalanced translocation between chromosomes 3 and 11 of the fetus. The mother proved to have a balanced reciprocal translocation between chromosomes 3 and 11. A grossly macerated hydropic male fetus was delivered with a flat nose and low implanted deformed ears. Histopathological examination revealed nuclear inclusion bodies in fetal erythroid cells, confirming human parvovirus B19 infection. Parvovirus B19 DNA was demonstrated by in situ hybridization in the nuclei of heart muscle cells. Our finding of two different disorders in one case illustrates the importance of a complete evaluation of every case of hydrops fetalis, especially concerning counselling on the outcome of future pregnancies. The human parvovirus B19 infection will not recur due to the acquired immunity of the mother, whereas the balanced reciprocal translocation will endanger future pregnancies.